EA200000709A1 - Бета-липотропин и его применения - Google Patents

Бета-липотропин и его применения

Info

Publication number
EA200000709A1
EA200000709A1 EA200000709A EA200000709A EA200000709A1 EA 200000709 A1 EA200000709 A1 EA 200000709A1 EA 200000709 A EA200000709 A EA 200000709A EA 200000709 A EA200000709 A EA 200000709A EA 200000709 A1 EA200000709 A1 EA 200000709A1
Authority
EA
Eurasian Patent Office
Prior art keywords
lipotropin
applications
fragments
analogues
analogs
Prior art date
Application number
EA200000709A
Other languages
English (en)
Inventor
Джеральд Вейн Бекер
Джон Пол Баттлер
Джон Эдвард Хейл
Уилльям Фрэнсис Джуниор Хит
Марк Луис Хейман
Бриджит Элизабет Шонер
Александр Дэвид Варшавский
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200000709A1 publication Critical patent/EA200000709A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/67—Lipotropins, e.g. beta, gamma lipotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

(57) Настоящее изобретение представляет выделенные нуклеиновые кислоты, векторы, трансформированные клетки-хозяева, аналоги, функциональные фрагменты и гибридные белки, касающиеся β-липотропина. Также представляются фармацевтические композиции, содержащие β-липотропин или его фрагменты и (или) аналоги, а также способы лечения сахарного диабета и состояний, связанных с ним, путем введения эффективного количества β-липотропина.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200000709A 1997-12-23 1998-12-21 Бета-липотропин и его применения EA200000709A1 (ru)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6865997P 1997-12-23 1997-12-23
US7985798P 1998-03-30 1998-03-30
US8632198P 1998-05-21 1998-05-21
US9138598P 1998-07-01 1998-07-01
US9540598P 1998-08-05 1998-08-05
US10397698P 1998-10-13 1998-10-13
PCT/US1998/027238 WO1999032142A1 (en) 1997-12-23 1998-12-21 Beta-lipotropin and uses thereof

Publications (1)

Publication Number Publication Date
EA200000709A1 true EA200000709A1 (ru) 2000-12-25

Family

ID=27557000

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000709A EA200000709A1 (ru) 1997-12-23 1998-12-21 Бета-липотропин и его применения

Country Status (18)

Country Link
US (2) US6323178B1 (ru)
EP (1) EP0926239A3 (ru)
JP (1) JP2001526061A (ru)
KR (1) KR20010024805A (ru)
CN (1) CN1284882A (ru)
AR (1) AR018532A1 (ru)
AU (1) AU1938599A (ru)
BR (1) BR9814433A (ru)
CA (1) CA2315888A1 (ru)
CO (1) CO4930304A1 (ru)
EA (1) EA200000709A1 (ru)
HR (1) HRP20000426A2 (ru)
HU (1) HUP0100132A2 (ru)
IL (1) IL136514A0 (ru)
PE (1) PE20000062A1 (ru)
PL (1) PL341293A1 (ru)
TR (1) TR200002611T2 (ru)
WO (1) WO1999032142A1 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002048337A2 (en) * 2000-12-13 2002-06-20 Incyte Genomics, Inc. Secreted human proteins
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US8227194B2 (en) * 2005-04-08 2012-07-24 University Of Maryland, Baltimore Monoclonal antibodies with binding specificity for response gene to complement 32 (RGC-32)
WO2009139846A1 (en) * 2008-05-12 2009-11-19 Department Of Veterans Affairs Automated system and method for diabetes control

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769326A (en) 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US5258496A (en) * 1990-07-10 1993-11-02 Scios Nova Inc. Isolation and purification of lung surfactant protein
JP3822232B2 (ja) * 1993-08-30 2006-09-13 ベイラー・カレッジ・オブ・メディシン 老化細胞由来ｄｎａ合成阻害因子
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
US5691309A (en) * 1995-01-31 1997-11-25 Eli Lilly And Company Anti-obesity proteins

Also Published As

Publication number Publication date
BR9814433A (pt) 2000-10-10
HUP0100132A2 (hu) 2001-05-28
CN1284882A (zh) 2001-02-21
US20030073621A1 (en) 2003-04-17
AU1938599A (en) 1999-07-12
CA2315888A1 (en) 1999-07-01
EP0926239A3 (en) 2002-08-28
US6323178B1 (en) 2001-11-27
AR018532A1 (es) 2001-11-28
PL341293A1 (en) 2001-04-09
EP0926239A2 (en) 1999-06-30
KR20010024805A (ko) 2001-03-26
PE20000062A1 (es) 2000-02-08
HRP20000426A2 (en) 2000-10-31
CO4930304A1 (es) 2000-06-27
TR200002611T2 (tr) 2000-12-21
JP2001526061A (ja) 2001-12-18
IL136514A0 (en) 2001-06-14
WO1999032142A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
RU95115239A (ru) Аналог эритропоэтина
PT96208A (pt) Processo de obtencao de uma sequencia de adn codificando um derivado recombinante do factor viii humano, de um vector e de celula recombinante e de preparacao do referido derivado.
EA200000872A1 (ru) Способы лечения диабета с помощью пептидных аналогов инсулина
DE69934967D1 (de) Verfahren zur verminderung der immunogenität von proteinen
EP1798239A3 (en) G-protein coupled receptors and uses therefor
PT93910A (pt) Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula
EA200901129A1 (ru) Нуклеиновые кислоты и полипептиды нового рецептора
BR0015137A (pt) Peptìdeos antigênicos de neisseria
EA199900939A1 (ru) Остеопротегерин-связывающие белки и рецепторы
ATE114169T1 (de) Morphogenetisches knochenprotein.
DE69027989D1 (de) Il-3 MIT ZUSÄTZLICHEN CYSTEINRESTEN UND CHEMISCHE MODIFIKATIONEN DAVON
EA200000652A1 (ru) Кристаллы глюкагоноподобного пептида 1
CA2381219A1 (en) Monomeric protein of the tgf-beta family
EA200000202A1 (ru) Рекомбинантная экспрессия c-пептида инсулина
DE69504808D1 (de) Corticotropin freisetzende rezeptoren des faktor 2
ES2150495T3 (es) Ligandos de flt3 purificados de mamifero y agonistas y antagonistas de los mismos.
Ouazana et al. Biochemical characterization of the cuticle collagen of the nematode Caenorhabditis elegans
EA200000709A1 (ru) Бета-липотропин и его применения
AMMER et al. The major protamine from stallion sperm. Isolation and amino-acid sequence
ATE233321T1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
ATE86260T1 (de) Peptid-molekuele, wirksam gegen gram-positive keime.
NO874704L (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
KR950003312A (ko) 연골세포 단백질